HOME >> MEDICINE >> NEWS
Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy

The paper is being published online this week in the Proceedings of the National Academy of Sciences.

"While a number of new drugs that inhibit new blood vessel growth are now available in the clinics, no one so far has been cured with available anti-angiogenic agents," said Professor Martin Friedlander, a Scripps Research scientist and retina specialist at Scripps Clinic who led the study. "Our study shows that combining anti-angiogenic agents that target multiple angiogenic pathways can significantly increase the effectiveness of such a therapeutic approach. Such combination angiostatic therapy provides a whole new range of treatment options for patients with neovascular diseases, where complete inhibition of new blood vessel growth is the desired result."

While new blood vessel growth from preexisting capillaries ("angiogenesis") is fundamental to survival, the abnormal formation of new blood vessels ("neovascularization") contributes to the pathogenesis of tumor growth and metastasis as well as the vast majority of diseases that lead to catastrophic loss of vision. A number of angiostatic molecules have been used to impair blood vessel formation as clinical adjuncts to conventional radio- and chemotherapy. Others have proven to be modestly effective in treating neovascular eye diseases.

The new study combined the actions of three classes of angiostatic compounds, each targeting different angiogenic pathways, and showed striking results in the treatment of an animal model of glioblastoma, a highly malignant brain cancer, and ischemic retinopathy, excessive blood vessel growth in the eye that is a major cause of blindness worldwide.

"Our combination therapy reduced tumor mass and increased survival in the glioblastoma model," Friedlander said. "In models of neovascular eye diseases, the therapy resulted in complete inhibition of pathological neovascularization in more than 60 percent of the eyes; over 90 percent had greate
'"/>

Contact: Marisela Chevez
mchevez@scripps.edu
858-784-2171
Scripps Research Institute
9-Jan-2007


Page: 1 2 3

Related medicine news :

1. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
2. Synthetic production of potential pharmaceuticals dramatically simplified by Scripps research team
3. The Scripps Research Institute, McDonalds align to fight childhood obesity and type 2 diabetes
4. Scripps research team reverses Friedreichs ataxia defect in cell culture
5. Scripps research scientists test anti-obesity vaccine
6. 1 of 2 pediatric kidney disease research centers in world established
7. Stanford researchers find culprit in aging muscles that heal poorly
8. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
9. Indiana University Imaging Center receives $6M grant for kidney research
10. Penn researchers discover novel pathway for increasing good cholesterol
11. New research discovers independent brain networks control human walking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/19/2019)... ... November 18, 2019 , ... ... for the scientific and healthcare industries, announced today the asset acquisition of ... known as Advantage Business Media) ceased operations after 13 years in June ...
(Date:11/19/2019)... ... November 19, 2019 , ... iPatientCare, a pioneer ... Patient Engagement solutions, announces Virtual User Conference (VUCON), which will highlight the impact ... better patient-centric experience. , VUCON sessions are designed to demonstrate ...
(Date:11/16/2019)... (PRWEB) , ... November 15, 2019 , ... ... adults living with memory impairment, has announced the Best Memory Care Facilities in ... to experts, facility features and amenities. , According to the Alzheimer’s ...
(Date:11/16/2019)... VEGAS (PRWEB) , ... November 15, 2019 , ... ... seen before in the United States, access to cannabis via well-managed dispensaries becomes ... marijuana industry. Wise Business Plans, industry-leading online provider of state-of-the-art, online, custom cannabis ...
(Date:11/16/2019)... LAUDERDALE, Fla. (PRWEB) , ... November 16, 2019 ... ... uniform provider to support AdventHealth, one of the nation’s largest faith-based health systems, ... kicked off a massive program implementation process – from product selection to fitting ...
Breaking Medicine News(10 mins):
(Date:11/19/2019)... ... 2019 , ... “Impact of the Biofield Energy Healing Based ... been named No. 1 International Best Seller and Hot New Release on Amazon ... Theory, and Mind-Body Connection in the USA, Canada, United Kingdom, and Australia. ...
(Date:11/19/2019)... ... 19, 2019 , ... HashCash Consultants is going to aid a major Pharma ... research initiative for precision drugs. , The collaboration is expected to streamline the process ... have more control over their genome records and the way it is used. They ...
(Date:11/16/2019)... ... 16, 2019 , ... International Splash Awards 2019 winners were announced and Srijan ... Srijan got nominated for its efforts at the world-class competition acknowledging the best Drupal ... tools and apps category. The event was organized in conjunction with DrupalCon Amsterdam on ...
Breaking Medicine Technology:
Cached News: